×
About 164 results

ALLMedicine™ Prostate Cancer Guidelines Center

Research & Reviews  19 results

ASTRO Editorial: The AUA-ASTRO-SUO Advanced Prostate Cancer Guidelines: A Continued but...
https://doi.org/10.1016/j.prro.2020.10.002
Practical Radiation Oncology; Zietman AL,

Dec 14th, 2020 - ASTRO Editorial: The AUA-ASTRO-SUO Advanced Prostate Cancer Guidelines: A Continued but Changing Role for the Radiation Oncologist.|2020|Zietman AL, ,|

A Comparison of Genitourinary Society Pathology and International Society of Urological...
https://doi.org/10.1016/j.eururo.2020.10.033
European Urology; Epstein JI, Kryvenko ON

Nov 15th, 2020 - In 2019, the Genitourinary Pathology Society (GUPS) and International Society of Urological Pathology (ISUP) held their own consensus conferences on prostate cancer grading and reporting, with separately published manuscripts. The majority of GUPS...

Biochemical Recurrence in Prostate Cancer: The European Association of Urology Prostate...
https://doi.org/10.1016/j.euf.2019.06.004
European Urology Focus; Van den Broeck T, van den Bergh RCN et. al.

Jun 29th, 2019 - Biochemical recurrence (BCR) after primary treatment of localized prostate cancer does not necessarily lead to clinically apparent progressive disease. To aid in prognostication, the European Association of Urology prostate cancer guidelines panel...

Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
https://jnccn.org/view/journals/jnccn/17/5/article-p479.xml
Journal of the National Comprehensive Cancer Network;

Apr 30th, 2019 - An estimated 174,650 new cases of prostate cancer will be diagnosed in 2019, accounting for 20% of new cancer cases in men.1 The age-adjusted death rates from prostate cancer have declined 51% from 1993 to 2016.1 Researchers have estimated that pr...

Estimating the healthcare costs of treating prostate cancer in Australia: A Markov mode...
https://doi.org/10.1016/j.urolonc.2017.10.024
Urologic Oncology; Gordon LG, Tuffaha HW et. al.

Nov 24th, 2017 - To estimate the health system costs of prostate cancer by disease risk category and treatment type over 2016 to 2025 and to identify potential strategies to contain the cost increase. A Markov cohort model was developed using clinical pathways fro...

see more →

Guidelines  57 results

ASTRO Editorial: The AUA-ASTRO-SUO Advanced Prostate Cancer Guidelines: A Continued but...
https://doi.org/10.1016/j.prro.2020.10.002
Practical Radiation Oncology; Zietman AL,

Dec 14th, 2020 - ASTRO Editorial: The AUA-ASTRO-SUO Advanced Prostate Cancer Guidelines: A Continued but Changing Role for the Radiation Oncologist.|2020|Zietman AL, ,|

Biochemical Recurrence in Prostate Cancer: The European Association of Urology Prostate...
https://doi.org/10.1016/j.euf.2019.06.004
European Urology Focus; Van den Broeck T, van den Bergh RCN et. al.

Jun 29th, 2019 - Biochemical recurrence (BCR) after primary treatment of localized prostate cancer does not necessarily lead to clinically apparent progressive disease. To aid in prognostication, the European Association of Urology prostate cancer guidelines panel...

Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
https://jnccn.org/view/journals/jnccn/17/5/article-p479.xml
Journal of the National Comprehensive Cancer Network;

Apr 30th, 2019 - An estimated 174,650 new cases of prostate cancer will be diagnosed in 2019, accounting for 20% of new cancer cases in men.1 The age-adjusted death rates from prostate cancer have declined 51% from 1993 to 2016.1 Researchers have estimated that pr...

Castration-Resistant Prostate Cancer
http://www.auanet.org/guidelines/castration-resistant-prostate-cancer-(2013-amended-2018)
Michael S. Cookson

Nov 30th, 2018 - As a direct result of the significant increase in multiple FDA-approved therapeutic agents for use in patients with metastatic castration-resistant prostate cancer (CRPC), clinicians are challenged with a multitude of treatment options and potenti.

Hypofractionated Radiation Therapy for Localized Prostate Cancer: Executive Summary of an AS...
https://www.practicalradonc.org/article/S1879-8500(18)30247-9/fulltext
Morgan, S.,et al.

Oct 10th, 2018 - External beam radiation therapy (EBRT) is a standard definitive treatment for men with localized prostate cancer. 1 The probability of cell survival after a dose of ionizing radiation is governed by the linear-quadratic model, in which curves of ce.

see more →

Clinicaltrials.gov  81 results

ASTRO Editorial: The AUA-ASTRO-SUO Advanced Prostate Cancer Guidelines: A Continued but...
https://doi.org/10.1016/j.prro.2020.10.002
Practical Radiation Oncology; Zietman AL,

Dec 14th, 2020 - ASTRO Editorial: The AUA-ASTRO-SUO Advanced Prostate Cancer Guidelines: A Continued but Changing Role for the Radiation Oncologist.|2020|Zietman AL, ,|

A Comparison of Genitourinary Society Pathology and International Society of Urological...
https://doi.org/10.1016/j.eururo.2020.10.033
European Urology; Epstein JI, Kryvenko ON

Nov 15th, 2020 - In 2019, the Genitourinary Pathology Society (GUPS) and International Society of Urological Pathology (ISUP) held their own consensus conferences on prostate cancer grading and reporting, with separately published manuscripts. The majority of GUPS...

Biochemical Recurrence in Prostate Cancer: The European Association of Urology Prostate...
https://doi.org/10.1016/j.euf.2019.06.004
European Urology Focus; Van den Broeck T, van den Bergh RCN et. al.

Jun 29th, 2019 - Biochemical recurrence (BCR) after primary treatment of localized prostate cancer does not necessarily lead to clinically apparent progressive disease. To aid in prognostication, the European Association of Urology prostate cancer guidelines panel...

Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
https://jnccn.org/view/journals/jnccn/17/5/article-p479.xml
Journal of the National Comprehensive Cancer Network;

Apr 30th, 2019 - An estimated 174,650 new cases of prostate cancer will be diagnosed in 2019, accounting for 20% of new cancer cases in men.1 The age-adjusted death rates from prostate cancer have declined 51% from 1993 to 2016.1 Researchers have estimated that pr...

Castration-Resistant Prostate Cancer
http://www.auanet.org/guidelines/castration-resistant-prostate-cancer-(2013-amended-2018)
Michael S. Cookson

Nov 30th, 2018 - As a direct result of the significant increase in multiple FDA-approved therapeutic agents for use in patients with metastatic castration-resistant prostate cancer (CRPC), clinicians are challenged with a multitude of treatment options and potenti.

see more →

News  7 results

Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
https://jnccn.org/view/journals/jnccn/17/5/article-p479.xml
Journal of the National Comprehensive Cancer Network;

Apr 30th, 2019 - An estimated 174,650 new cases of prostate cancer will be diagnosed in 2019, accounting for 20% of new cancer cases in men.1 The age-adjusted death rates from prostate cancer have declined 51% from 1993 to 2016.1 Researchers have estimated that pr...

NCCN Tightens Active Surveillance in Prostate Cancer Guidelines
https://www.mdedge.com/familymedicine/article/33530/oncology/nccn-tightens-active-surveillance-prostate-cancer-guidelines/page/0/1
Family Practice News;

Apr 6th, 2011 - Unlike zoledronic acid, which is administered intravenously and can potentially affect renal function, denosumab is given subcutaneously and does not affect kidney function, he said; as such, it represents a "novel treatment option. " The updated N.

AUA Updates Prostate Cancer Guidelines
https://www.onclive.com/publications/obtn/2007/june2010/cover_story_june2007

Jul 11th, 2010 - The American Urological Association (AUA) released its updated comprehensive guidelines for the management of clinically localized prostate cancer. This update represents the first revision to the AUA guidelines since they were initially published...

Active Surveillance Now Prominent in NCCN Prostate Cancer Guidelines
https://www.staging.medscape.com/viewarticle/715129

Jan 13th, 2010 - January 14, 2010 — For the first time, the National Comprehensive Cancer Network's (NCCN) practice guidelines for prostate cancer recommend the use of active surveillance as the sole initial treatment — not just an option — for many men with prost...

Active Surveillance Now Prominent in NCCN Prostate Cancer Guidelines
https://www.medscape.com/viewarticle/715129

Jan 13th, 2010 - January 14, 2010 — For the first time, the National Comprehensive Cancer Network's (NCCN) practice guidelines for prostate cancer recommend the use of active surveillance as the sole initial treatment — not just an option — for many men with prost...

see more →